AKT1 and neoplasm: Blocking the PI3K/Akt signaling pathway can reverse the drug resistance and restore the sensitivity of tumor cells to many kinds of chemotherapeutic drugs, which was validated in our own experiment by using nasopharyngeal carcinoma cell lines [8].